Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Effectiveness of Pascoflair Using Qantitative Measurement of Electric Brain Activity During Examination Stress in 40 Subjects Suffering From Test Anxiety. A Double-blind, Randomized, Placebo-controlled, 2-armed, Phase IV Study in Parallel Design.

NCT05049447 is registered in ClinicalTrials.gov with Pascoe Pharmazeutische Praeparate GmbH as lead sponsor.

NCT NCT05049447
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05049447 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Effectiveness of Pascoflair Using Qantitative Measurement of Electric Brain Activity During Examination Stress in 40 Subjects Suffering From Test Anxiety. A Double-blind, Randomized, Placebo-controlled, 2-armed, Phase IV Study in Parallel Design.
Lead sponsor
Pascoe Pharmazeutische Praeparate GmbH
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2015
Completion date
August 31, 2015
Enrollment
40 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain activity, passiflora incarnata, stress, test anxiety